Artiva Biotherapeutics, Inc. (ARTV)
3.09
+0.02
(+0.65%)
USD |
NASDAQ |
Dec 11, 16:00
3.09
0.00 (0.00%)
After-Hours: 16:44
Artiva Biotherapeutics Total Liabilities (Quarterly): 19.64M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Ovid Therapeutics, Inc. | 19.15M |
| Kezar Life Sciences, Inc. | 14.75M |
| Olema Pharmaceuticals, Inc. | 44.96M |
| Disc Medicine, Inc. | 57.06M |
| NovaBay Pharmaceuticals, Inc. | 1.853M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 148.86M |
| Shareholders Equity (Quarterly) | 129.22M |
| Debt to Equity Ratio | 0.0905 |
| Current Ratio | 11.65 |
| Net Debt Paydown Yield | 1.17% |